Volume 9, Number 7—July 2003
Hantaviruses in São Paulo State, Brazil
Highlight and copy the desired format.
|EID||Figueiredo LT, Moreli ML, Campos GM, Sousa RL. Hantaviruses in São Paulo State, Brazil. Emerg Infect Dis. 2003;9(7):891-892. https://dx.doi.org/10.3201/eid0907.030087|
|AMA||Figueiredo LT, Moreli ML, Campos GM, et al. Hantaviruses in São Paulo State, Brazil. Emerging Infectious Diseases. 2003;9(7):891-892. doi:10.3201/eid0907.030087.|
|APA||Figueiredo, L. T., Moreli, M. L., Campos, G. M., & Sousa, R. L. (2003). Hantaviruses in São Paulo State, Brazil. Emerging Infectious Diseases, 9(7), 891-892. https://dx.doi.org/10.3201/eid0907.030087.|
To the Editor: Hantavirus pulmonary syndrome (HPS) is an emerging health problem in Brazil. This syndrome was first reported in 1993 in three persons living in a rural area of Juquitiba County; two of them died of acute respiratory failure (1). Although Juquitiba County is part of the metropolitan area of greater São Paulo City, patients lived in a recently deforested region. From 1993 through 2002, approximately 200 HPS cases were reported in Brazil, with a 40% case-fatality ratio (Ministry of Health of Brazil, Report on Hantavirus cases 1993–2002, unpub. data).
The wild rodent Bolomys laziurus is believed to be the most important hantavirus reservoir in the State of São Paulo, based on high levels of specific antibodies observed in serum from captured specimens (L.E. Pereira, Adolpho Lutz Institute, pers. comm., 2001). The economy of the inland region of Ribeirão Preto in the State of São Paulo, with its 3.5 million inhabitants, is based on the sugar cane agroindustry. The region has been almost completely deforested, with important consequences to the environment and wild rodent ecology. Twenty HPS cases were reported in Ribeirão Preto in the last 5 years, with a 60% case-fatality ratio. Review of medical records showed that a prodromic fever occurred in all 14 case-patients studied; dyspnea, cough, hypotension, and tachycardia occurred in about two thirds of patients; and hemorrhagic phenomena (hematuria, melena, and hypermenorrhea) in about one third. Thrombocytopenia was observed in all the patients, elevated hematocrit in about three fourths, and leukocytosis with neutrophilia and a left shift in the differential count in about two thirds. Serum creatinine levels were also increased (average level 2 mg/dL). Chest radiographs showed diffuse alveolar flocculant infiltrates in most cases (2,3). Laboratory diagnosis of HPS was made by serologic testing (enzyme-linked immunosorbent assay [ELISA]) in 18 cases and by reverse transcription–polymerase chain reaction (RT-PCR) in 11 cases; for 7 cases, both techniques were used. We performed a nucleotide sequence analysis of the N gene of hantavirus (residues 236–477) obtained from the blood of 11 of the 20 patients. This analysis showed that the infections were caused by Araraquara virus, a previously known hantavirus that had been detected by RT-PCR in the serum of an HPS patient living in a nearby county (4). Thus, Araraquara virus is the causative agent of a severe form of HPS, with a high death rate. This high death rate could also be related to the lack of adequate initial therapy provided by clinicians who probably did not immediately suspect HPS and may have not recommended hospitalization in intensive-care units. In addition, some hospitalized patients were in shock when first seen and were rehydrated with massive quantities of fluids, which may have aggravated pulmonary edema and contributed to death.
The occurrence of 10% of the Brazilian HPS reported cases in Ribeirão Preto indicates that this region is suitable for studying the epidemiology of hantavirus infections. A serologic survey conducted in the region in 1999, which included 567 primary-care patients from Ribeirão Preto, Guariba, and Jardinópolis Counties, found that 7 (1.23%) of them had immunoglobulin (Ig) G antibodies to Sin Nombre virus by ELISA and that 5 of those lived in Jardinópolis (population 30,000), a county where a fatal case of HPS occurred in 1999 (5). Thus, Jardinópolis County was chosen for a population-based survey. In May 2001, we obtained personal information and collected fingerprick blood samples from 818 participants, 15–70 years of age, living in urban and rural areas of the county. IgG antibodies to the N recombinant protein of Andes virus were detected by ELISA in the blood samples of 14.3% of the participants (5). Even though all HPS cases in Ribeirão Preto were associated with rural activity and rodent exposure, these serologic data suggest that hantavirus infections are common in Jardinópolis County, independent of sex, profession, or history of contact with rodents. None of the 14.3% participants with IgG antibodies to hantavirus had a history of HPS-like disease, and the ELISA test showed cross-reactions with most of the South American hantaviruses, including Araraquara. Persons living in the urban area had higher levels of antibodies to hantavirus than those from rural areas. In Ribeirão Preto, the physical boundaries of cities have expanded to incorporate other areas, encroaching upon rural areas with many popular subsidized housing complexes. Work-related and recreational rural activities in that region are also frequent, which makes it difficult to interpret these data. These results suggest that in this region of southeast Brazil, hantaviruses may be causing undiagnosed asymptomatic or clinically minor infections in addition to typical HPS. This finding envokes important questions. Is more than one hantavirus circulating in this region, causing mostly benign infections? Is Araraquara virus widespread, causing mostly inapparent infections and only rarely causing HPS? Would HPS be associated with some predisposing condition in the infected person? If more than one hantavirus is circulating in the region, could urban rodents be reservoirs?
Further studies are necessary to better understand the epidemiology and clinical signs and symptoms of hantavirus infection in the region of Ribeirão Preto. Such studies should emphasize determining the reservoirs, the modes of virus transmission to people, and the possible distinct clinical forms of hantavirus infections.
We thank the employees of the Health Bureau of the County of Jardinópolis for the dedicated collaboration on the serologic survey and Paula Padula for supplying antigen for enzyme-linked immunoabsorbent assays.
This work was supported by the State of São Paulo Research Foundation (FAPESP).
- Iversson LB. Hantavirus pulmonary syndrome in the rural area of Juquitiba, São Paulo Metropolitan Area, Brazil. Rev Inst Med Trop Sao Paulo. 1997;39:237–8.
- Figueiredo LTM, Moreli ML, Kashima S, Almeida VSO, Félix PR, Bruno JC, Hantavirus pulmonary syndrome (HPS) in Guariba, SP, Brazil. Report of 2 cases. Rev Inst Med Trop Sao Paulo. 1999;41:131–7.
- Figueiredo LTM, Campos GM, Rodrigues FB. Síndrome pulmonar e cardiovascular por hantavirus: aspectos epidemiológicos, clínicos, do diagnóstico laboratorial e do tratamento. [in Portuguese]. Rev Soc Bras Med Trop. 2001;34:15–27.
- Johnson AM, de Souza LT, Ferreira IB, Pereira LE, Ksiazek TG, Rollin PE, Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol. 1999;59:527–35.
- Holmes RR, Boccanera R, Figueiredo LTM, Mançano SR, Pane C. Seroprevalence of human hantavirus infection in Ribeirão Preto Region of São Paulo State, Brazil. Emerg Infect Dis. 2000;6:560–1.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Luiz Tadeu Moraes Figueiredo, Faculdade de Medicina de Ribeirão Preto–USP, Av. Bandeirantes 3900, Ribeirão Preto, SP, 14049-900, Brazil; fax: 55 16 6336695
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 22, 2010
- Page last updated: December 22, 2010
- Page last reviewed: December 22, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)